Critical Reviews in Oncology/Hematology

5 ta ish

Jurnal · ISSN 1040-8428

1. Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions

   Chou‐Yi Hsu, Harikumar Pallathadka, Saade Abdalkareem Jasim +7

   Sharh maqolaCAR-T cell therapy researchCritical Reviews in Oncology/Hematology20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.review-article.000011

2. Phage therapy in cancer treatment: Mechanisms, emerging innovations, and translational progress

   Chou‐Yi Hsu, D. Polatova, Rania Hamad +7

   Sharh maqolaBacteriophages and microbial interactionsCritical Reviews in Oncology/Hematology20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.review-article.000059

3. Epigenetic mechanisms and next-gen editing platforms in hematology: From molecular basis to therapeutic frontiers

   Minzhi Huang, Ahmad Ewadi, Nazli Servatian +6

   Sharh maqolaCRISPR and Genetic EngineeringCritical Reviews in Oncology/Hematology20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.review-article.000099

4. Pharmacomicrobiomics in blood cancers: How the gut microbiome and its metabolites shape drug efficacy and toxicity

   Chou-Yi Hsu, Yasir Qasim Almajidi, Mohammad Abohassan +7

   MaqolaGut microbiota and healthCritical Reviews in Oncology/Hematology20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.000310

5. Overcoming conditional immune resistance in MSS and pMMR colorectal cancer: A sequential gating framework for immunotherapy

   Husni Farah, Djamila Polatova, Jasur Rizaev +5

   MaqolaCancer Immunotherapy and BiomarkersCritical Reviews in Oncology/Hematology20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.015085